The AI company Anthropic has officially filed for an initial public offering (IPO) on the global Nasdaq exchange, a move that paves the way for what could become the largest IPO in history, surpassing the record-breaking offering of SpaceX, which raised $86 billion last June, and outpacing its competitor OpenAI in the race to public markets.
Rapid Financial Growth and Massive Losses
The 335-page offering documents showed that the revenue of the company behind the Claude assistant has grown exponentially to reach more than $16 billion in the first half of the current year, recording 14 times the revenue of the same period last year. However, the company recorded a net loss of $80.7 billion in the first half of 2026, which included a one-time accounting cost of $72.4 billion related to financing agreements.
Despite these losses, projections indicate that Anthropic's market capitalization could jump to between $1.5 trillion and $2 trillion, exceeding its previous valuation in private funding rounds of $965 billion, which could place it among the most valuable public companies in the world alongside companies like Tesla.
Ownership Structure and Risk Management
The company plans to list its shares under the ticker symbol "ANT" with the goal of raising funds that could reach $100 billion to expand infrastructure and acquire new technologies to compete with tech giants. Through special class shares, the seven founders, including CEO Dario Amodei and his sister, COO Daniela Amodei, will retain 50.1% of shareholder voting power.
The structure also included the appointment of independent members to a "Long-Term Benefit Trust" to protect the public interest and ensure that financial aspects do not take precedence over the safety and technology of artificial intelligence.
Warnings of Existential Risks and Regulatory Constraints
The offering documents included about 100 pages dedicated to stating "risk factors," including scenarios related to the possibility of AI models going out of control and performing tasks that threaten human life or pose an existential risk, in addition to regulatory challenges and ongoing disputes with the U.S. government over military technology applications.